Thermo Fisher Scientific Inc. TMO
NYSE
| 09/26/2026 | 06/27/2026 | 03/28/2026 | 12/31/2025 | 09/27/2025 | |
|---|---|---|---|---|---|
| Revenue | 8.27% | 7.23% | 5.36% | 3.91% | 3.22% |
| Total Other Revenue | -100.00% | -100.00% | -- | -- | -- |
| Total Revenue | 8.27% | 7.23% | 5.36% | 3.91% | 3.22% |
| Cost of Revenue | 8.50% | 7.80% | 6.26% | 4.47% | 2.33% |
| Gross Profit | 7.93% | 6.42% | 4.08% | 3.12% | 4.52% |
| SG&A Expenses | 6.54% | 3.90% | 1.14% | -0.90% | -0.63% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -546.67% | -546.67% | -546.67% | -550.00% | 2,900.00% |
| Total Operating Expenses | 7.20% | 6.05% | 4.27% | 2.52% | 1.80% |
| Operating Income | 12.89% | 12.46% | 10.25% | 10.22% | 9.88% |
| Income Before Tax | 10.07% | 8.05% | 5.68% | 3.86% | 5.26% |
| Income Tax Expenses | 36.40% | 36.93% | 10.59% | -16.87% | -15.13% |
| Earnings from Continuing Operations | 7.89% | 6.14% | 5.32% | 6.01% | 7.40% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -340.00% | -- | -350.00% | -325.00% | -135.71% |
| Net Income | 7.64% | 5.82% | 5.11% | 5.81% | 7.07% |
| EBIT | 12.89% | 12.46% | 10.25% | 10.22% | 9.88% |
| EBITDA | 12.45% | 9.69% | 5.88% | 4.26% | 3.06% |
| EPS Basic | 9.59% | 7.47% | 6.54% | 7.09% | 8.26% |
| Normalized Basic EPS | 12.09% | 11.68% | 10.59% | 10.00% | 11.10% |
| EPS Diluted | 9.43% | 7.42% | 6.56% | 7.19% | 8.51% |
| Normalized Diluted EPS | 12.01% | 11.82% | 10.80% | 10.27% | 11.38% |
| Average Basic Shares Outstanding | -1.78% | -1.51% | -1.31% | -1.18% | -1.11% |
| Average Diluted Shares Outstanding | -1.71% | -1.64% | -1.50% | -1.43% | -1.36% |
| Dividend Per Share | 9.52% | 9.76% | 10.00% | 10.26% | 10.53% |
| Payout Ratio | 0.00% | 0.03% | 0.03% | 0.03% | 0.02% |